Scarica l'app Stockscreener
2.935
2.62%
0.075
Dopo l'orario di chiusura:
2.99
0.055
+1.87%
Precedente Chiudi:
$2.86
Aprire:
$2.9
Volume 24 ore:
231.40K
Relative Volume:
0.78
Capitalizzazione di mercato:
$372.98M
Reddito:
-
Utile/perdita netta:
$-57.09M
Rapporto P/E:
-6.4977
EPS:
-0.4517
Flusso di cassa netto:
$-51.43M
1 W Prestazione:
+17.40%
1M Prestazione:
-12.39%
6M Prestazione:
+94.37%
1 anno Prestazione:
+339.44%
Intervallo 1D:
$2.73
$2.9899
Intervallo di 1 settimana:
$2.485
$3.0256
Portata 52W:
$0.62
$4.3101
Nautilus Biotechnology Inc Stock (NAUT) Company Profile
Nome
Nautilus Biotechnology Inc
Settore
Industria
Telefono
206-333-2001
Indirizzo
2701 EASTLAKE AVE EAST, SEATTLE
Compare NAUT vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NAUT
Nautilus Biotechnology Inc
|
2.935 | 363.45M | 0 | -57.09M | -51.43M | -0.4517 |
VRTX
Vertex Pharmaceuticals Inc
|
427.52 | 107.87B | 12.32B | 4.34B | 3.19B | 16.86 |
REGN
Regeneron Pharmaceuticals Inc
|
721.05 | 73.63B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
807.55 | 49.42B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
303.01 | 40.20B | 3.71B | 313.75M | 465.38M | 2.2571 |
ONC
Beone Medicines Ltd Adr
|
313.32 | 33.06B | 5.36B | 287.73M | 924.18M | 2.5229 |
Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-05 | Downgrade | Goldman | Neutral → Sell |
| 2024-06-27 | Iniziato | Guggenheim | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2022-01-06 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-11-02 | Iniziato | Cowen | Outperform |
| 2021-08-04 | Iniziato | Goldman | Neutral |
| 2021-07-13 | Iniziato | Jefferies | Buy |
Mostra tutto
Nautilus Biotechnology Inc Borsa (NAUT) Ultime notizie
Nautilus Biotechnology (NASDAQ:NAUT) Is In A Good Position To Deliver On Growth Plans - Yahoo Finance
Nautilus Biotechnology (NAUT) price target increased by 60.00% to 4.08 - MSN
Nautilus expects cash runway through 2027 while targeting oncology early access in H2 2026 - MSN
NAUT Stock Price, Quote & Chart | NAUTILUS BIOTECHNOLOGY INC (NASDAQ:NAUT) - ChartMill
What revision trend Nautilus Biotechnology (NAUT)? (Spikes) 2026-05-01Trending Stock Ideas - Newser
Nautilus Biotechnology (NAUT) outlines 2026 shareholder votes on directors, pay and auditor - Stock Titan
Nautilus Biotechnology (NASDAQ: NAUT) details Q1 2026 loss and cash runway - Stock Titan
Nautilus Biotechnology Plans Voyager Platform Launch for Late 2026 - HarianBasis.co
Nautilus Biotechnology Q1 Earnings Call Highlights - MarketBeat
Nautilus Biotechnology (NASDAQ:NAUT) Announces Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Nautilus Biotechnology Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Nautilus Biotechnology Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Nautilus Biotechnology Reports First Quarter 2026 Financial Results - Investing News Network
Earnings call transcript: Nautilus Biotechnology beats Q1 2026 EPS forecast - Investing.com
Earnings call transcript: Nautilus Biotechnology beats Q1 2026 EPS forecast By Investing.com - Investing.com Canada
Nautilus Biotechnology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Q1 2026: Nautilus Biotechnology (NASDAQ: NAUT) cuts costs and narrows loss - Stock Titan
Sentinel Trust Co. LBA Purchases New Position in Nautilus Biotechnology, Inc. $NAUT - MarketBeat
Nautilus Biotechnology Inc expected to post a loss of 14 cents a shareEarnings Preview - TradingView
Nautilus Biotechnology launches recruitment drive for Iterative Mapping Early Access Program - Traders Union
Here is why Nautilus Biotechnology (NAUT) is one of the best life sciences penny stocks to buy - MSN
Nautilus Biotechnology CEO joins Biocom panel on AI impact in biotech sector - Traders Union
Nautilus Biotechnology (NAUT) Expected to Announce Earnings on Tuesday - MarketBeat
Nautilus Biotechnology (NAUT) Stock: Fair Value Assessment (Institutional Selling) 2026-04-20High Beta Stocks - Xã Vĩnh Công
Nautilus Biotechnology details how artificial intelligence transforms proteomics insights - Traders Union
Nautilus Biotechnology, Inc. (NASDAQ:NAUT) Sees Significant Increase in Short Interest - MarketBeat
Here is Why Nautilus Biotechnology (NAUT) is One of the Best Life Sciences Penny Stocks to Buy - Insider Monkey
How does Nautilus Biotechnology Inc compare to its peersProduct Launch & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Published on: 2026-04-11 15:42:56 - baoquankhu1.vn
Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026 - Investing News Network
NAUT PE Ratio & Valuation, Is NAUT Overvalued - Intellectia AI
NAUT Technical Analysis & Stock Price Forecast - Intellectia AI
Published on: 2026-03-31 08:20:41 - baoquankhu1.vn
Nautilus Biotechnology And 2 Other Compelling Penny Stocks For Your Watchlist - Sahm
Nautilus Biotechnology accelerates with Voyager Platform launch and first customer announcements - Traders Union
Nautilus Biotechnology at Investor Summit: Innovative Proteomics Pathway By Investing.com - Investing.com India
Nautilus Biotechnology Unveils Voyager Proteomics Platform, Targets Beta Access in 2H and Launch Next Year - marketbeat.com
Nautilus Biotechnology (NASDAQ:NAUT) Sets New 52-Week HighWhat's Next? - MarketBeat
Aug Chart Watch: Is Nautilus Biotechnology Inc forming a breakout patternTrade Entry Report & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference - bitget.com
Nautilus management presents online March 25; webcast stays available - Stock Titan
Technical Analysis: Is Nautilus Biotechnology Inc stock a smart retirement pick2026 Earnings & Comprehensive Market Scan Insights - baoquankhu1.vn
Nautilus Biotechnology Inc Azioni (NAUT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.77%
0.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):